ArticleFrontiers in medicine2025
Patient acceptance of AI-assisted diabetic retinopathy screening in primary care: findings from a questionnaire-based feasibility study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trust in AI-Supported Screening in General Practice Among Urban and Rural Citizens: Cross-Sectional Study.JMIR medical informatics · 2026Article
- Patient Perspectives on Artificial Intelligence-Based Diabetic Retinopathy Screening at an Urban US Medical Center.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This feasibility study investigates patients' acceptance of AI-assisted diabetic retinopathy screening (DRS) in primary care. Method: Patients with type 2 diabetes from 12 primary care settings in Denmark underwent AI-assisted DRS as part of routine diabetes care and completed a questionnaire covering demographics, recent DRS, general health, mental well being, trust in physician, competence in diabetes self-care, distrust in AI, and acceptance of future DRS. Results: 298 patients participated and completed the questionnaire. Acceptance of future AI-assisted DRS in primary care was higher than that of ophthalmologist-led screening, although patients still showed distrust toward AI. Findings indicated that greater competence in diabetes self-care was associated with higher acceptance of future AI-assisted DRS in primary care. Lower distrust in AI increased acceptance of future AI-assisted DRS in primary care, while higher distrust increased acceptance of ophthalmologist-led DRS. Conclusion: This study found that most patients accepted future AI-assisted DRS in primary care. Associations between acceptance and the factors examined are very small and may have limited or no clinical impact. Other factors, such as convenience of having DRS in primary care, may influence patient's acceptance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.